Abstract:Background Previous studies have indicated that anti-citrullinated protein antibody (ACPAs) titers are associated with the presence and severity of interstitial lung disease (ILD) in RA. The lung might be a site of initiation of immunity to citrullinated proteins. Previous studying anti-citrullinated HSP90 (citHSP90β) profiles between bronchial veolarlavage fluid (BALF) and serum indicated the lung plays a direct role in shaping the immune repertoire of RA-ILD. Objectives Whether citHSP90β contributes to the initiation or perpetuation of autoimmune interstitial lung abnormalities (ILA) in RA remains to be clarified. To address this issue we investigated the spontaneous T cell responses to the putative autoantigen citrullinated HSP90β in different stages of RA-ILD. Methods In RA-no ILD (n=19), indeterminate ILD (ILA1) (n=24), subclinical RA-ILD (ILA 2) (n=20), clinical RA-ILD (ILA3) (n=4) and other connective tissue disease associated ILD (CTD-ILD) (n=14) patients. Cultures derived from whole blood were individually stimulated with HSP90β, citHSP90β, citrullinated BSA, or no antigen. The concentration of 13 cytokines and chemokines in the plasma supernatant were then measured using Luminex xMAP technology. Results CitHSP90β induced significantly higher levels of IFN-γ levels in RA-ILD (ILA=2+3) groups compared to the RA-no ILD group (p=0.002), but did not stimulate the production of other cytokines (p>0.05). Furthermore, citHSP90β did not stimulate the production of IFN-γ or other cytokines stimulated those individuals with non-RA CTD-ILD (p=0.1039, IFN-g). Conclusions The production of IFN-γ by T cells stimulated with citHSP90b demonstrates a bias toward TH1 immune responses that are likely involved in the pathogenesis of RA-ILD. The presence of autoreactive Th1-like cells in RA patients in conjunction with citrullinated autoantigens may indicate the involvement of this autoantigen in the pathogenesis of RA-ILD. Early targeting of the immune reactions in the lung might therefore be a new approach to modulate disease. References Chen J, Doyle TJ, Liu Y, Aggarwal R, Wang X, Shi Y, et al. Biomarkers of rheumatoid arthritis-associated interstitial lung disease. Arthritis & rheumatology. 2015; 67:28–38. Harlow L, Rosas IO, Gochuico BR, Mikuls TR, Dellaripa PF, Oddis CV, et al. Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis and rheumatism. 2013; 65:869–79. Bongartz T, Cantaert T, Atkins SR, Harle P, Myers JL, Turesson C, et al. Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology (Oxford). 2007; 46:70–5. Nijenhuis S, Zendman AJ, Vossenaar ER, Pruijn GJ, vanVenrooij WJ. Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clinica chimica acta; international journal of clinical chemistry. 2004; 350:17–34. Disclosure of Interest None declared

A Citrullinated Antigenic Vaccine in Treatment of Autoimmune Arthritis

Restoring Immunological Tolerance in Established Experimental Arthritis by Combinatorial Citrullinated Peptides and Immunomodulatory Signals

Impact of Citrullination Upon Antigenicity of Fibrinogen

Citrullinated Peptide And Its Relevance To Rheumatoid Arthritis: An Update

Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis

A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis

Immune tolerance of citrullinated peptides

[T Cell Proliferative Response and Antibody Formation to Citrullinated Collagen Type II in Patients with Rheumatoid Arthritis].

Antibodies to Citrullinated Proteins: Molecular Interactions and Arthritogenicity

An innovative immunotherapeutic strategy for rheumatoid arthritis: Selectively suppressing angiogenesis and osteoclast differentiation by fully human antibody targeting thymocyte antigen-1

Adoptive Induced Antigen-Specific Treg Cells Reverse Inflammation in Collagen-Induced Arthritis Mouse Model

The Autoantibody Response to Cyclic Citrullinated Collagen Type II Peptides in Rheumatoid Arthritis.

In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells

Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine

ACPA Mediates the Interplay Between Innate and Adaptive Immunity in Rheumatoid Arthritis.

Antigen-specific therapy of rheumatoid arthritis

Identification of Lipopolysaccharide‐binding Protein As a Novel Citrullinated Autoantigen in Rheumatoid Arthritis

Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis

Structural Basis of Cross‐Reactivity of Anti–Citrullinated Protein Antibodies

Cytokine Regulation and Fast Inflammation Resolution in Early Rheumatoid Arthritis by Cerium-Modified Gold Nanoclusters

AB1167 Autoreactive T Cells to Citrullinated HSP90 in Interstitial Lung Disease in Rheumatoid Arthritis